These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23258240)

  • 41. Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease.
    Manco M; Ciampalini P; DeVito R; Vania A; Cappa M; Nobili V
    Pediatr Nephrol; 2009 Jun; 24(6):1211-7. PubMed ID: 19242728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: a descriptive analysis.
    Kruger FC; Daniels C; Kidd M; Swart G; Brundyn K; Van Rensburg C; Kotze MJ
    S Afr Med J; 2010 Mar; 100(3):168-71. PubMed ID: 20459941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital.
    Mondal E; Karim MR; Begum A; Hassan K; Noor SM; Khan MM; Khan KH; Ashrafuzzaman SM
    Mymensingh Med J; 2023 Apr; 32(2):338-347. PubMed ID: 37002743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome.
    Castro-Martínez MG; Banderas-Lares DZ; Ramírez-Martínez JC; Escobedo-de la Peña J
    Cir Cir; 2012; 80(2):128-33. PubMed ID: 22644007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity.
    De Nucci S; Bonfiglio C; Donvito R; Di Chito M; Cerabino N; Rinaldi R; Sila A; Shahini E; Giannuzzi V; Pesole PL; Coletta S; Lanzilotta E; Piazzolla G; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic Kidney Disease in Non-Diabetic Older Adults: Associated Roles of the Metabolic Syndrome, Inflammation, and Insulin Resistance.
    Zammit AR; Katz MJ; Derby C; Bitzer M; Lipton RB
    PLoS One; 2015; 10(10):e0139369. PubMed ID: 26431218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey.
    Kotronen A; Yki-Järvinen H; Männistö S; Saarikoski L; Korpi-Hyövälti E; Oksa H; Saltevo J; Saaristo T; Sundvall J; Tuomilehto J; Peltonen M
    BMC Public Health; 2010 May; 10():237. PubMed ID: 20459722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?
    Tarantino G; Finelli C
    World J Gastroenterol; 2013 Jun; 19(22):3375-84. PubMed ID: 23801829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference.
    Tominaga K; Fujimoto E; Suzuki K; Hayashi M; Ichikawa M; Inaba Y
    Environ Health Prev Med; 2009 Mar; 14(2):142-9. PubMed ID: 19568858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease.
    Aller R; Castrillon JL; de Luis DA; Conde R; Izaola O; Sagrado MG; Velasco MC; Alvarez T; Pacheco D
    Ann Hepatol; 2011; 10(1):50-5. PubMed ID: 21301010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Abdominal fat depots and their association with insulin resistance in patients with type 2 diabetes.
    Garg UK; Mathur N; Sahlot R; Tiwari P; Sharma B; Saxena A; Jainaw RK; Agarwal L; Gupta S; Mathur SK
    PLoS One; 2023; 18(12):e0295492. PubMed ID: 38064530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Metabolic Score for Insulin Resistance Index is Superior to the Triglyceride and Glucose Index in Identifying Nonalcoholic Fatty Liver Disease in Hyperuricemia Subjects.
    Shu Y; Huang G; Mao Y
    Diabetes Metab Syndr Obes; 2023; 16():4235-4246. PubMed ID: 38169634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease.
    Aller R; de Luis DA; Izaola O; Sagrado MG; Conde R; Velasco MC; Alvarez T; Pacheco D; González JM
    Dig Dis Sci; 2009 Aug; 54(8):1772-7. PubMed ID: 19005759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease.
    Nobili V; Alisi A; Vania A; Tiribelli C; Pietrobattista A; Bedogni G
    BMC Med; 2009 May; 7():21. PubMed ID: 19409076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects].
    Lizardi-Cervera J; Laparra DI; Chávez-Tapia NC; Ostos ME; Esquivel MU
    Rev Gastroenterol Mex; 2006; 71(4):453-9. PubMed ID: 17542278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology.
    Della Corte C; Fintini D; Giordano U; Cappa M; Brufani C; Majo F; Mennini C; Nobili V
    Clin Endocrinol (Oxf); 2013 Jul; 79(1):49-54. PubMed ID: 22789032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of lifestyle habits, nutritional status and insulin resistance in NAFLD.
    Malavolti M; Battistini NC; Miglioli L; Bagni I; Borelli L; Marino M; Scaglioni F; Bellentani S
    Front Biosci (Elite Ed); 2012 Jan; 4(3):1015-23. PubMed ID: 22201932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study.
    Yadav V; Mendiratta V; Agrawal A; Bisherwal K; Singh R; Meena AK
    Indian J Dermatol; 2023; 68(4):377-384. PubMed ID: 37822394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study.
    Ryoo JH; Choi JM; Moon SY; Suh YJ; Shin JY; Shin HC; Park SK
    Atherosclerosis; 2013 Apr; 227(2):398-403. PubMed ID: 23390894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease.
    Baršić N; Lerotić I; Smirčić-Duvnjak L; Tomašić V; Duvnjak M
    World J Gastroenterol; 2012 Aug; 18(30):3945-54. PubMed ID: 22912545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.